ScienceCareers Advertising

Science Magazine

Description

http://www.vt.edu/academics/academic-departments.html. College ... Virginia Tech is an AA/EEO employer; applications from .... about five years of postdoc experience. ...... is supported by such documents as photocopies of advanced .... seeking an innovative Vice President for Research and Economic Development (VPR) ...

Informations

• Publié par: paul.vallen
• Nombre de lectures: 21
• Langue: English
• Poids de l'ouvrage: 6 Mo

Extrait

We’re Looking for World-Class Faculty. Come Invent the Future with Us.

............................................................................................................................................................ Virginia Tech plans to recruit 100 COLLEGES faculty members during ltsentm.hep-dtmarcadamecidameci/st.edu/ac://www.vptth 2011-12. Searches will focus on College of Agriculture and Life Sciences faculty members who will contribute College of Architecture and Urban Studies to four discovery areas from the Pamplin College of Business university’s strategic plan: College of Engineering Energy, Materials, and Environment alertsArdHananumlloCoegebiLf entronmEnvisandeoe esncieSc   Health, Food, and Nutrition CcnecSeiegfoloel gllCoecruoseRlarutaNf  Innovative Technologies and College of Veterinary Medicine Complex Systems  Social and Individual RESEARCH INSTITUTES Transformation httpseaecr.h/:w/wwr.i/ude.tvetutitsnx.deins/pph Faculty members will be recruited SeicLnfinItsneeceitut erCrvita liraF across the eight colleges to promote tstituferorCticialTechnoloppildecSe , i y c t n is e trAnd,achTelonogyInstefotitu growth in these and other research luC,erutEdnarivnmeonnt gyandA IsntituteforSoci I e n ty areas. Virginia Bioinformatics Institute Please visit www. r ost. Virginia Tech Carilion Research Institute reviewfacultysea p rc o h v esa v s t t .e h d ey ut a o re Virginia Tech Transportation Institute launched across the fall semester. Virginia Tech is an AA/EEO employer; applications from members of underrepresented groups are especially encouraged. ............................................................................................................................................................. TOP EMPLOYERS

Faculty Position The Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology (http://ki.mit.edu/) invites applications for a junior or senior faculty appointment. The Koch Institute is an NCI-designated Cancer Center which features research across a wide range of areas in cancer biology and cancer-oriented engineering. This is an open search with regard to field of study and specific research focus, but clear cancer relevance of the proposed research program is essential. Areas of interest include, but are not limited to: imaging, proteomics, single-cell analysis, systems biology, metastasis, stem cell biology, and novel approaches to detecting, monitoring and treating cancer. The candidate(s) will be expected to develop and lead an internationally competitive research program as well as participate in undergraduate and graduate teaching. The successful candidate(s) will have laboratory space in the recently opened Koch Institute building and a faculty appointment in an appropriate department at MIT. The deadline for the complete application with letters is November 1, 2011. Please apply at https://academicjobsonline.org/ajo/jobs/926 The David H. Koch Institute for Integrative Cancer Research at MIT is an Equal Employment Opportunity/Affirmative Action Employer.

BASIC SCIENCE RESEARCH DIRECTOR, ASIA. Estee Lauder Companies, a global innovator in prestige skincare, is seeking an MD or PhD with focus on dermatology or related fields to manage its growing basic science research program in Asia, headquartered in Shanghai, China. The position includes directing basic and clinical research, collaborating with academic institutions, supporting product development, representing the companys research to the Asian press, and communicating with and travel to the companys research centers in Europe and New York. The candidate should have 5+ years working in basic or clinical research, preferably with time in the personal care industry. The candidate should have strong people management and networking skills, and excellent communication in English and Chinese. Estee Lauder provides a generous and competitive compensation package. Please submit a cover letter summarizing goals and qualifications together with resume toMs. Jing Cheng,[e-mail].

orP SREE ybdecud CUFOARCONS PublishSCustomneecA/AAtehSic RVSUEYOYPLSEROT ec MEP gniiffO

Continuous innovation and outstanding research are e mos mpor an a r u es to respondents choosing this years best biotech and pharma companiesyet to top employers, their scientists ingenuity and enthusiasm are the real essentials for excellence By Carol Milano

byneecSicfor our science-driven culture, and to come out so high in our first year. Eight of this years top 20 companies are based in Europe. Global collaborations and concerns are increasingly important to leading biotech/pharma companies, which pay careful attention to their re- search facilities and services in devel- oping countries. Health care provid- 7 N 9 e   a p r e ly r   cent    wo   rk in    the United S   tate   s, and    40 p   ercen   t are ,    "We choose people who ers in less-developed areas may not female.   aren't afraid to take risks have access to the newest medical procedures and pharmaceutical treat- ex B p e e s c i t d   e a  s  l i e n a n d o in va g t   i c o o n  m a p n a d  n r y e   s t e o  ar b c e h   ,  s s o u c r i v al e ly y    r r e e s s p p o o n n d si e b n l t e s ,    by trying something new or s.ment treat its employees with respect, and inspire their loyalty. bringing a nontraditional idea Denmark-based Novo Nordisk (#9 T c h e i s s s   f y u e ll a y r,    t m h a e k  # e 5 s     c c r h it a e n ri g a e  s   n h e a e s d  a e   d t   o t p o  l   e k aders h hi e p     o t r h g a a t  n s iz u a c - - forwardand who are not this year, and also new to the top 20 tion moving in the right directionrep e la e c p e  t d 2010s has  i fied with the status quo." p r a e o d m d   in n s y st i   c h u a t    c a a i l sc r   a fi h i p t e n c i a   m    s a i     g   c e e n p o s list) erna- sat s t a D   r c i l v e in ar g     v C is h i a o r n a   c o t f e   r w is h ti e c r s e     c t h h a e r   t o  o rg n  a p n . i   z 1 a 2 ti 0 o .) n is headed. (See  Lisa Kelly-Croswell, senior nal needtioset erta .iDbate fntou - c acs ntme crep 57 tuoba roovo of Nent    The 2011 results brought a new, first-time #1 employer: vice president, Vertex  provide TheyNordisks business. Vertex Pharmaceuticals Incorporated (#3 in 2010). In fact, training about best practices in dia- three of the highest-ranking companies are new to the top st betes care for thousands of physicians in China. Diabetes doesnt (see Top 20 Employers chart on p. 116for complete company listing). get the attention it deserves there because of limited resources,  These shifts arent surprising, because Its been an interesting time observesSteve Chinn,vice president for human resources. Were in the industry, observes Alan Smith,Genzyme Corporations chief striving to be a partner with the Chinese health care system, not scientific officer before its acquisition by Sanofi. For us, the past simply as just a maker of medicine, but by doing more to help year has been a period of upheaval, but weve regularly scored well educate and inform patients and physicians about the severity of in this survey, he notes (Genzyme is #13 this year, #8 in 2010). Now the disease. chief science advisor for Sanofi Global Research and Development, he says, As part of Sanofi, well take the approach weve used at SELECTING THE SCIENTISTS Genzyme and apply it more generally. Being an innovative leader continues to be the most powerful Other top employers are entering new phases, too. Vertex re-  driver for selecting a company as a top employer. When asked to cently introduced their fi rst drug, Incivek, to the market, and began describe what makes the best company, the best, survey respon- building their fi rst commercial team. This [survey] recognition is dents specifi cally mentioned supports a culture of innovation,  tied directly to the passion and creativity that our 1,800 employees employee-driven curiosit  and innovative ideas of everyone are y, bring to Vertex each day, as we seek to change the lives of peo- considered. ple with devastating diseases, says Peter Mueller,    How do top employers create an innovative and inspiring corporateVertexs chief science officer and executive vice president for global research atmosphere? Among many highly qualified applicants, they search and development. for the exceptional scientists most likely to bring fresh, original ideas Regeneron Pharmaceuticals, Inc. (#2, and new to the top 20 list) to the company. » has a treatment for a major eye disease under FDA review. Later this At Novo Nordisk, Chinn specifies one priority:continued  year, theyll seek FDA approval for a new cancer drug and request an additional application for Arcalyst, their first product on the market. UPCOMING FEATURES Since Arcalyst was created for a rare genetic condition, Regeneron is now essentially developing a brand-new sales and marketing func-  Focus on EuropeOctober 21 tion. ExplainsRoss Grossman,  Emerging FieldsNovember 4 Neuroscience: human resources vice president, Weve focused a great deal of energy on retaining a true biotech culture[stressing] innovation and great scienceas weve grown  Focus on ChinaDecember 9 and matured as a company. Its especially gratifying to be recognized

151 wwceraeesr.wcseicn.org

FOCUS ON CAREERS Produced by theScineec/AAAS Custom Publishing Office TOP EMPLOYERS SURVEY  o SURVEY    T Tw p enty ODTHOGOLYEM  Employers survey was R 2 a 0 n 11 k 2 R 0 an 10 k Employer (Global Headquarters)  24 to arch pril 11, 2011 by Brighton Con- 1 3 Vertex Pharmaceuticals Incorporated (Cambridge, MA)    sulting Group and Cell Associ- 2 – Regeneron Pharmaceuticals, Inc. (Tarrytown, NY)    ates. For this years survey, a     mixed methodology was again 3 1 Genentech (South San Francisco, CA)    used. 419 Pioneer Hi-Bred, a DuPont busi IA) (Johnston,     The first part of this meth- ness       odology included e-mailed 5 4 The Takeda Oncology Company (Cambridge, MA)Millennium:    invitations to roughly 46,000       individuals who were located 610 Amgen (Thousand Oaks, CA)    worldwide. These individuals ma wereScience visitors website 7 6 Boehringer Ingelheim (Ingelheim, Ger ny)     who have registered with AAAS 8 7 Syngenta (Basel, Switzerland)    and past survey respondents. 9 – Novo Nordisk (Bagsvaerd, Denmark)    This year Facebook, Twitter, and    online banner ads were also 10 15 Biogen Idec (Weston, MA)     used to promote participation in 11 13 Abbott (Abbott Park, IL)    this survey. Forty-two percent      of all surveys submitted were       12 9 Merck KGaA/Merck Serono/EMD Serono (Darmstadt, Germany)    from this first effort. The second part of the meth- 138 Genzyme Corp. (Cambridge, MA)    odology included an e-mail blast 14 11 Novartis (Basel, Switzerland)    to a list of about 500 human    resource contacts at industry 155 Roche (Basel, Switzerland)     firms that were pulled from 16 2 Monsanto Company (Creve Coeur, MO)    theScienceCareers sales data-    base. The remaining 58 percent 1714 Eli Lilly and Company (Indianapolis, IN)     of the surveys were from this 18 17 Gilead Sciences (Foster City, CA)    second effort.      19 20 AstraZeneca PLC (London, UK)    This report is based on a     total sample of 3,784 survey 20 – Bayer (Leverkusen, Germany)    edno.stnresp      The 20 companies with the best reputations as employers and the top three driving characteristics for each company, according to respondents in the 2011 survey undertaken for theScience/AAAS Custom Publishing  Office. The companies without a 2010 rank did not rank among the top 20 in the 2010 survey. Passion about diabetes and hemophilia, the two diseases for trying something new or bringing a nontraditional idea forwardand which the company creates medications. We want people who are  who are not satisfied with the status quo. very knowledgeable and educated about these disease states, and Their research and development group hires for what we who are known within their fi eld for the research theyve done or for want to be, not what we are today, says Vertexs Mueller, who  being thought leaders. looks for people with the scientific and technologic expertise Bayers U.S. division seeks scientists with the ingenuity, to take Vertex to the next frontier, and the courage to constantly curiosity, and enthusiasm for working at an organization striving for move the frontier forward. In science, experiments often have innovations that make a difference in the world, summarizes Bryanunexpected outcomes. Some scientists have the willingness Iams, and of external communications. In a global company director joy to deal with this uncertainty. Thats the phenotype operating in every country, can they be respectful and understand were looking for. that in different cultures, different beliefs drive people? he asks. Mueller wants his scientists maximally integrated across all func- With 108,000 employees worldwide, the Germany-based company tionsresearch, development, commercial, legal, human resources, (#20; reappearing on the list since being #19 in 2006) looks for accountingso they can communicate and collaborate. Thats fun- versatility and the kind of entrepreneurial thinking encouraged at damental to our ultimate goal: Discovering and developing transfor- Bayers innovation centers in China, Europe, and California. These mational medicines. then hook into and get translated into our larger global organization, Genzyme prefers highly trained scientists, several years be- explains Iams. yond their Ph.D.s. Our best hires, in a creative sense, have Its sometimes easy to hire someone just because they are an about five years of postdoc experience. Theyre really where the exceptional scientist, but we spend ample time to fi nd a person excitement is in researchand theyre exciting to be around,  with the technical skills who also fi ts with our core values, says says Smith.   Lisa  ,llewsorC-ylleKVertex's senior vice president of human In 2008, needing several hundred additional employees for a new resources. We choose people who arent afraid to take risksby collaboration with Sanofi-Aventis, Regeneron workedcontinued » 116 ics.ecneerac.sreorgwww